Home » Topics » BioWorld Science

BioWorld Science
RSS

Jazz and Werewolf announce global license and collaboration agreement to develop WTX-613

April 8, 2022

Small molecule inhibitors of natural killer group 2D identified at Janssen

April 8, 2022

GPR30 is a therapeutic target in triple-negative inflammatory breast cancer

April 8, 2022

IKZF1 gain-of-function variants tied to T/B cell-related immune dysregulation

April 7, 2022

Emergex collaborates with nonprofit organization to advance yellow fever booster vaccine candidate

April 7, 2022

New TYK2 inhibitors identified by Esker Therapeutics

April 7, 2022

Merck & Co. synthesizes new GLCT-1 inhibitors

April 7, 2022

Aurigene Discovery Technologies presents CREBBP and/or KAT3B inhibitors

April 7, 2022

Sunshine Lake Pharma discloses thyroid hormone receptor beta agonists

April 7, 2022

Medshine Discovery patents new sGC activators

April 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...